Navigation Links
Digital Healthcare Announces Appointment of Dr. Suber Huang as Medical Director
Date:11/15/2007

Suber S. Huang, MD, MBA, will serve as Digital's Medical Director for

Ophthalmology

WAKE FOREST, N.C., Nov. 15 /PRNewswire/ -- Digital Healthcare, a Wake Forest, NC company specializing in retinal risk assessment for diabetics, announced today that Suber S. Huang, MD, MBA has been named Medical Director for Ophthalmology. Dr. Huang will provide the company expert advice and counsel regarding product development and development.

Dr. Huang is the Philip F. and Elizabeth G. Searle-Suber Huang, MD, Professor and Vice Chairman in the Department of Ophthalmology and Visual Sciences, University Hospitals Case Medical Center, Cleveland, Ohio. He is the Director of Vitreoretinal Diseases and Surgery, the Director of Clinical Research, and the Director of the Retinal Diseases Image Analysis Reading Center (REDIARC). Dr. Huang serves on the Executive Board of Directors for the American Society of Retina Specialists, the world's largest organization of retinal specialists. Dr. Huang is the Director of the Diabetic Eye Disease Committee of the National Eye Health Education Program and the serves on the Ophthalmic Technology Assessment Committee (OTAC)-Retina/Vitreous Panel and on the Research, Regulatory, and External Scientific Relations Committee, both committees associated with the American Academy of Ophthalmology.

"Having one of the country's premier retinal specialists on our team will be invaluable," said Marc Winchester, President, North America and Board Director of Digital Healthcare. "Retasure is focused on retinal health and, we will rely on Dr. Huang's vast medical expertise to advise us on future product enhancements. With Dr. Huang's input, Retasure will continue to be the industry's leading retinal risk assessment tool."

"Retasure is a terrific system that provides benefits for patients at risk for diabetic retinopathy," said Dr. Huang. "Earlier detection of patients with diabetic eye disease by endocrinologists and primary care physicians will mean earlier referral to an ophthalmologist. Early diagnosis and treatment of complications is critical to reduce the chance of permanent visual loss. As a retinal specialist and advocate, I am excited about promoting and enhancing a service that benefits our whole health system."

The FDA-approved Retasure program provides a simple, affordable, and non- invasive solution that allows physicians to capture their patients' retinal images during a three to five minute procedure. Images are transmitted over a secure, HIPPA compliant network to an accredited reading center. A state-licensed and board certified ophthalmologist reviews the images and results are returned to the original physician within 72 hours.

There are an estimated 20 million diabetic patients in the US, but only about half have any retinal assessments, despite a high risk of diabetic retinopathy. The National Eye Institute indicates diabetic retinopathy is the leading cause of blindness among working age American adults. More than a million patients around the world have received a retinal risk assessment using Digital Healthcare software.

About Digital Healthcare

Digital Healthcare is the global leader in retinal risk assessment. They are the world's leading provider of care management programs for diabetic retinopathy. Their award-winning MS-HUG technology is used by leading hospitals and research centers including University Hospitals Case Medical Center at Case Western Reserve University, The Wilmer Eye Institute at The Johns Hopkins University and the United States Military. Digital Healthcare's Retasure solution offers several advantages for primary care and endocrinologist physicians and their patients: It can be operated by non-clinicians; it is non-invasive and requires no dilation; it obtains exceptionally high-quality digital images of the retina using a simple-to-operate fundus camera; it returns results quickly to the ordering physicians; and it encourages patient compliance for retinal evaluation and comprehensive eye examinations.


'/>"/>
SOURCE Digital Healthcare Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Digital Healthcare Wins FDA Approval for Retasure
2. Digital Healthcare Wins FDA Approval for Retasure
3. Astra Tech Acquires Innovative Dental Digital Technology Company
4. Digital Info Security Company and DGF MedServ, Inc. Announce Intent to Partner in Marketing DGIF IT Solutions to Medical Industry
5. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
6. Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director
7. Siemens Rolls Out Its First Mobile Digital Mammography System in the U.S.
8. SMRT Architects and Engineers Selected to Design New $115M Digital X-Ray Manufacturing Facility for GE Healthcare
9. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
10. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
11. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... Amada Senior Care, premier provider of non-medical in-home ... – its San Antonio West location. Prior to entering the senior care industry, Amada ... opening of Amada San Antonio West will take place on Friday, April 29th. ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... the development of miniature microphones and headsets announced today that the US Patent ... of integrating in-earphones into a structure. This innovative design creates a lightweight and ...
(Date:4/28/2016)... ... , ... Metabolic Nutrition today announced the upcoming launch of its ... Get Fit and Sports Expo in Orlando, Florida. Attended by pro athletes, ... 29-30, was selected as the perfect event to introduce the highly anticipated GlycoLoad. ...
(Date:4/28/2016)... ... April 28, 2016 , ... The Aging in ... has established an ICD-10-CM code for sarcopenia, giving it recognition for separate reporting and ... effective October 1, 2016. , Sarcopenia is defined as a combination of low muscle ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... to those affected by a health insurance co-operative bankruptcy to receive their ... individuals can receive over 1,500 FDA-approved prescription medications from over 180 American ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... PUNE, India , April 28, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" is a report ... pipeline and helps strengthen R&D pipelines by identifying ... best-in-class products. Company Profiles discussed in ... Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
(Date:4/27/2016)...   , Total Sales Grow ... Clinical sales grow 16% year-over-year  , ... MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... ended March 31, 2016 and provided an update on ... First Quarter 2016 Revenue Results by Category  ...
Breaking Medicine Technology: